Skip to content
OpenCapital
Get started

Bio-Rad Laboratories BIO EBITDA margin

EBITDA margin at other companies

Abbott logo
AbbottABT
24.1%-0.2pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
22.1%+0.3pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
24.2%-0.2pp
Danaher logo
DanaherDHR
29.2%-0.9pp
Revvity logo
RevvityRVTY
26.6%-2.0pp
Agilent Technologies logo
Agilent TechnologiesA
25.3%-0.2pp

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×